Immune reconstitution during Pneumocystis lung infection: Disruption of surfactant component expression and function by S-nitrosylation

Journal of Immunology

Volumn 182, Issue 4, 2009, Pages 2277-2287

  Atochina Vasserman, Elena N ^a   Gow, Andrew J ^b   Abramova, Helen ^a   Guo, Chang Jiang ^b   Tomer, Yaniv ^a   Preston, Angela M ^c   Beck, James M ^c   Beers, Michael F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; COLLECTIN; LUNG SURFACTANT; PHOSPHOLIPID; SURFACTANT PROTEIN B; SURFACTANT PROTEIN D;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXEMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NITROSYLATION; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS; PNEUMOCYSTIS MURINA; PNEUMOCYSTIS PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY FAILURE; SPLEEN CELL; ANIMAL; C57BL MOUSE; CHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; PNEUMONIA, PNEUMOCYSTIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 61449239078     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802775     Document Type: Article

References (73)

1. Stansell, J. D., D. H. Osmond, E. Charlebois, L. LaVange, J. M. Wallace, B. V. Alexander, J. Glassroth, P. A. Kvale, M. J. Rosen, L. B. Reichman, et al. 1997. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons: Pulmonary Complications of HIV Infection Study Group. Am. J. Respir. Crit. Care Med. 155: 60-66.
2. Su, T. H., and W. J. Martin, 2nd. 1994. Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu. Rev. Med. 45: 261-272.
3. Kovacs, J. A., J. W. Hiemenz, A. M. Macher, D. Stover, H. W. Murray, J. Shelhamer, H. C. Lane, C. Urmacher, C. Honig, and D. L. Longo. 1984. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100: 663-671.
4. Huang, L., A. Morris, A. H. Limper, J. M. Beck, and on behalf of the ATS Pneumocystis Workshop Participants. 2006. An Official ATS Workshop Summary: recent advances and future directions in Pneumocystis pneumonia (PCP). Proc. Am. Thorac. Soc. 3: 655-664.
5. Kovacs, J. A., V. J. Gill, S. Meshnick, and H. Masur. 2001. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. J. Am. Med. Assoc. 286: 2450-2460.
6. Beers, M. F., E. N. Atochina, A. M. Preston, and J. M. Beck. 1999. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J. Lab. Clin. Med. 133: 423-433.
7. Atochina, E. N., M. F. Beers, S. T. Scanlon, A. M. Preston, and J. M. Beck. 2000. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant. Am. J. Physiol. 278: L599-L609.
8. Atochina, E. N., J. M. Beck, S. T. Scanlon, A. M. Preston, and M. F. Beers. 2001. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. J. Lab. Clin. Med. 137: 429-439.
9. Wright, T. W., R. H. Notter, Z. D. Wang, A. G. Harmsen, and F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 69: 758-764.
10. Wiedmann, H. P. 1996. Surfactant and acquired lung diseases. J. Lab. Clin. Med. 127: 239-241.
11. Martin, W. J., and J. R. Wright. 1999. Pneumocystis carinii pneumonia and pulmonary surfactant. J. Lab. Clin. Med. 133: 406-407.
12. Griese, M. 1999. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 13: 1455-1476.
13. Rooney, S. A., S. L. Young, and C. R. Mendelson. 1994. Molecular and cellular processing of lung surfactant. FASEB J. 8: 957-967.
14. Crouch, E. C. 1998. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 19: 177-201.
15. Possmayer, F. 1988. A proposed nomenclature for pulmonary surfactant-associated proteins. Am. Rev. Respir. Dis. 138: 990-998.
16. Curstedt, T., H. Jornvall, B. Robertson, T. Bergman, and P. Berggren. 1987. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant: characterization and biophysical activity. Eur. J. Biochem. 168: 255-262.
17. Weaver, T. E., C. L. Na, and M. Stahlman. 2002. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin. Cell Dev. Biol. 13: 263-270.
18. Crouch, E. C., and J. R. Wright. 2001. Surfactant proteins A and D and pulmonary host defense. Annu. Rev. Physiol. 63: 521-554.
19. Crouch, E., K. Hartshorn, and I. Ofek. 2000. Collectins and pulmonary innate immunity. Immunol. Rev. 173: 52-65.
20. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5: 58-68.
21. Crouch, E., A. Persson, D. Chang, and J. Heuser. 1994. Molecular structure of pulmonary surfactant protein D (SP-D). J. Biol. Chem. 269: 17311-17319.
22. Crouch, E., D. Parghi, S. F. Kuan, and A. Persson. 1992. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am. J. Physiol. 263: L60-L66.
23. Zhang, P. N., A. McAlinden, S. Li, T. Schumacher, H. L. Wang, S. S. Hu, L. Sandell, and E. Crouch. 2001. The amino-terminal heptad repeats of the coiled-coil neck domain of pulmonary surfactant protein D are necessary for the assembly of trimeric subunits and dodecamers. J. Biol. Chem. 276: 19862-19870.
24. 2-terminal cysteine residues and collagen helix formation to assembly and secretion. J. Biol. Chem. 271: 18912-18919.
25. Guo, C. J., E. N. Atochina-Vasserman, E. Abramova, J. P. Foley, A. Zaman, E. Crouch, M. F. Beers, R. C. Savani, and A. J. Gow. 2008. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 6: e266.
26. Barry, S. M., M. C. I. Lipman, A. R. Deery, M. A. Johnson, and G. Janossy. 2002. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med. 3: 207-211.
27. Koval, C. E., F. Gigliotti, D. Nevins, and L. M. Demeter. 2002. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin. Infect. Dis. 35: 491-493.
28. Wislez, M., E. Bergot, M. Antoine, A. Parrot, M. F. Carette, C. Mayaud, and J. Cadranel. 2001. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 164: 847-851.
29. Wu, A. K. L., V. C. C. Cheng, B. S. F. Tang, I. F. N. Hung, R. A. Lee, D. S. Hui, and K. Y. Yuen. 2004. The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review. BMC Infect. Dis. 4: 57.
30. Cheng, V. C. C., I. F. N. Hung, A. K. L. Wu, B. S. F. Tang, C. M. Chu, and K. Y. Yuen. 2004. Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts. Eur. J. Clin. Microbiol. Infect. Dis. 23: 512-514.
31. Beck, J. M., M. J. Rosen, and H. H. Peavy. 2001. Pulmonary complications of HIV infection: Report of the Fourth NHLBI Workshop. Am. J. Respir. Crit. Care Med. 164: 2120-2126.
32. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1999. Chemokine gene expression during Pneumocystis carinii driven pulmonary inflammation. Infect. Immun. 67: 3452-3460.
33. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104: 1307-1317.
34. Bhagwat, S. P., F. Gigliotti, H. D. Xu, and T. W. Wright. 2006. Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease. Am. J. Physiol. 291: L1256-L1266.
35. Chen, W. X., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis-carinii pneumonia in severe combined immunodeficient mice: morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73: 709-720.
36. + T-cells into severe combined immunodeficiency mice. J. Clin. Invest. 90: 673-678.
37. Shellito, J. E., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectivity depleted of helper T lymphocytes. J. Clin. Invest. 85: 1686-1693.
38. Beck, J. M., and A. G. Harmsen. 1998. Lymphocytes in host defense against Pneumocystis carinii. Semin. Respir. Infect. 13: 330-338.
39. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937-945.
40. Beers, M. F., S. R. Bates, and A. B. Fisher. 1992. Differential extraction for the rapid purification of bovine surfactant protein B. Am. J. Physiol. 262: L773-L778.
41. Beers, M. F., A. Wali, M. F. Eckenhoff, S. I. Feinstein, J. H. Fisher, and A. B. Fisher. 1992. An antibody with specificity for surfactant protein C precursors: identification of pro-SP-C in rat lung. Am. J. Respir. Cell Mol. Biol. 7: 368-378.
42. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128: 477-487.
43. Beck, J. M., H. D. Liggit, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59: 3859-3862.
44. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J. Immunol. 161: 360-366.
45. + T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108: 1469-1474.
46. Phares, T. W., R. B. Kean, T. Mikheeva, and D. C. Hooper. 2006. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 176: 7666-7675.
47. +T-cellmediated antitumor immune response in murine models of lung cancer and mesothelioma. Cancer Res. 65: 11752-11761.
48. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 72: 248-254.
49. Bartlett, G. R. 1959. Phosphorous assay in column chromatography. J. Biol. Chem. 234: 466-468.
50. Atochina, E. N., A. J. Gow, J. M. Beck, A. Haczku, A. Inch, H. Kadire, Y. Tomer, C. Davis, A. M. Preston, F. Poulain, et al. 2004. Surfactant protein D deficient mice exhibit delayed clearance of Pneumocystis lung infection with increased inflammation and altered nitric oxide metabolism. J. Infect. Dis. 189: 1528-1539.
51. Enhorning, G. 2001. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129: 221-226.
52. Jaffrey, S. R., and S. H. Snyder. 2001. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001: pl1.
53. Casey, J., J. Kaplan, E. N. Atochina-Vasserman, A. J. Gow, H. Kadire, Y. Tomer, J. H. Fisher, S. Hawgood, R. C. Savani, and M. F. Beers. 2005. Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am. J. Respir. Crit. Care Med. 172: 869-877.
54. Fang, K. Z., N. V. Ragsdale, R. M. Carey, T. Macdonald, and B. Gaston. 1998. Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem. Biophys. Res. Commun. 252: 535-540.
55. Meissner, N. N., S. Swain, M. Tighe, A. Harmsen, and A. Harmsen. 2005. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection. J. Immunol. 174: 5462-5471.
56. + T lymphocyte subsets and host defense against Pneumocystis carinii. J. Infect. Dis. 181: 2011-2017.
57. Pottratz, S., and A. L. Weir. 1995. Attachment of Pneumocystis carinii to primary cultures of rat alveolar epithelial cells. Exp. Cell Res. 221: 357-362.
58. Beck, J. M., A. M. Preston, J. G. Wagner, S. E. Wilcoxen, P. Hossler, S. R. Meshnick, and R. Paine. 1998. Interaction of rat Pneumocystis carinii and rat alveolar epithelial cells in vitro. Am. J. Physiol. 19: L118-L125.
59. Garvy, B. A., J. A. Wiley, F. Gigliotti, and A. G. Harmsen. 1997. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65: 5052-5056.
60. Shellito, J. E., J. K. Kolls, R. Olariu, and J. M. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173: 432-439.
61. Ischiropoulos, H., M. F. Beers, S. T. Ohnishi, D. Fisher, S. Garner, and S. R. Thom. 1996. Nitric oxide production and perivascular tyrosine nitration in brain following carbon monoxide poisoning in the rat. J. Clin. Invest. 97: 2260-2267.
62. Genovese, T., S. Cuzzocrea, R. Di Paola, M. Failla, E. Mazzon, M. Sortino, G. Frasca, E. Gili, N. Crimi, A. Caputi, and C. Vancheri. 2005. Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycininduced lung injury. Respir. Res. 6: 58.
63. Borron, P., R. A. Veldhuizen, J. F. Lewis, F. Possmayer, A. Caveney, K. Inchley, R. G. McFadden, and L. J. Fraher. 1996. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am. J. Respir. Cell Mol. Biol. 15: 115-121.
64. Borron, P., J. C. McIntosh, T. R. Korfhagen, J. A. Whitsett, J. Taylor, and J. R. Wright. 2000. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. 278: L840-L847.
65. Koptides, M., T. M. Umstead, J. Floros, and D. S. Phelps. 1997. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am. J. Physiol. 17: L382-L388.
66. Atochina, E. N., M. F. Beers, S. Hawgood, F. Poulain, C. Davis, T. T. Fusaro, and A. J. Gow. 2003. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am. J. Respir. Cell Mol. Biol. 30: 271-279.
67. Atochina, E. N., J. M. Beck, A. M. Preston, A. Haczku, Y. Tomer, S. T. Scanlon, T. Fusaro, J. Casey, S. Hawgood, A. J. Gow, and M. F. Beers. 2004. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect. Immun. 72: 6002-6011.
68. Hawgood, S., C. Brown, J. Edmondson, A. Stumbaugh, L. Allen, J. Goerke, H. Clark, and F. Poulain. 2004. Pulmonary collectins modulate strain-specific influenza A virus infection and host responses. J. Virol. 78: 8565-8572.
69. Clark, H., N. Palaniyar, P. Strong, J. Edmondson, S. Hawgood, and K. B. M. Reid. 2002. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J. Immunol. 169: 2892-2899.
70. Gardai, S. J., Y. Q. Xiao, M. Dickinson, J. A. Nick, D. R. Voelker, K. E. Greene, and P. M. Henson. 2003. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23.
71. Limper, A. H., D. M. O'Riordan, Z. Vuk-Pavlovic, and E. C. Crouch. 1994. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia. J. Eukaryot. Microbiol. 41: 98S.
72. Beers, M. F., R. G. Johnson, and A. Scarpa. 1986. Evidence for an ascorbate shuttle for the transfer of reducing equivalents across chromaffin granule membranes. J. Biol. Chem. 261: 2529-2535.
73. Wang, J., F. Gigliotti, S. P. Bhagwat, S. B. Maggirwar, and T. W. Wright. 2007. Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am. J. Physiol. 292: L1495-L1505.